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Arg8-vasopressin (AVP), a circadian clock-controlled gene product, is released from the hypothalamic suprachiasmatic nuclei (SCN) in
mice in a circadian fashion. Previously reported differences in two mouse lines, initially selected for thermoregulatory nest-building behavior
(building small nests (S-mice) or big nests (B-mice)) with different circadian organization of behavior and in number of SCN-AVP
immunoreactive neurons, were further investigated. We confirmed and expanded the finding that S-mice exhibited constant high levels of
SCN-AVP content with no apparent circadian rhythmicity, whereas B-mice had lower numbers of AVP positive cells which varied with time
of day. We found that AVP mRNA expression levels at midnight and midday were similar in both lines, as established by in situ
hybridization. When AVP transport and release were blocked by colchicine, SCN-AVP immunoreactivity was similar in both lines. This
suggests that differences in SCN-AVP content depend on transport or release. Organotypic SCN cultures of B-mice showed more AVP
release per neuron than cultures of S-mice. These results reveal that on a mechanistic level the mouse lines differed in transport and/or release
of AVP in the SCN, rather than differential regulation of AVP gene transcription or number of AVP immunoreactive neurons.
D 2005 Elsevier B.V. All rights reserved.Theme: Neural basis of behavior
Topic: Biological rhythms and sleep
Keywords: Nest-building behavior; Clock-controlled gene; House mouse; Vasopressin; Circadian1. Introduction
Arg8-vasopressin (AVP) has been recognized as a clock-
controlled output system of the SCN, but its precise role is0006-8993/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.brainres.2005.07.068
Abbreviations: AVP, arginine vasopressin; SCN, suprachiasmatic nuclei
of the hypothalamus; PVN, paraventricular nucleus of the hypothalamus;
SON, supraoptic nucleus of the hypothalamus; S-mice, mice building small
nests; B-mice, mice building big nests; ExT, external time; ZT, zeitgeber
time; PD, postnatal day; -ir, immunoreactivity; OD, optical density
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1 Contributed equally to this work.still poorly understood [16,22,36,39,43]. Circadian rhythms
in SCN-AVP are observed both in vivo and in vitro, at the
level of mRNA transcription [29], mRNA quantities [10],
peptide content [25,26], and peptide release [30,42,46].
Although an output role of AVP has been hypothesized
[22,39], the peptide is not a prerequisite for restoring
circadian locomotor rhythms by fetal grafts in SCN-lesioned
rats and hamsters [3,18,31] and in SCN-intact old rats [32].
Brattleboro rats lacking AVP expression are behaviorally
rhythmic, albeit with a decreased amplitude [38].
Both SCN-AVP content and release correlate significantly
with the degree of circadian organization of locomotor
behavior in common voles,Microtus arvalis. In behaviorally(2005) 16 – 25
D.R. Van der Veen et al. / Brain Research 1060 (2005) 16–25 17non-rhythmic subjects of this rodent species, in vivo SCN-
AVP content is high and in vitro AVP release low with no
daily fluctuation in long-term organotypic SCN cultures. In
behaviorally rhythmic voles, both in vivo SCN-AVP content
and in vitro AVP release show a circadian rhythm [17,26–
28]. Reduced SCN-AVP content correlates with increased
loss of circadian rhythmicity in old voles [44]. SCN-AVP
content also correlates with more subtle differences in
circadian organization of locomotor behavior in house mouse
lines bidirectionally selected for thermoregulatory nest-
building behavior (mice building small or big nests referred
to as S- and B-mice, respectively). Mice with robust circadian
organization (S-mice) have a 1.5-fold higher number of SCN-
AVP cells than mice with less robust circadian organization
(B-mice) [1,7–9]. A similar correlation was found in
different rat strains [49], but not in mice selected for high
levels of voluntary wheel running activity [20] suggesting a
possible role of mouse strain genetic background.
The goal of this study was to examine whether previously
reported mouse strain-specific differences in the number of
SCN-AVP neurons of S- and B-mice [7] are also present at
different time points and whether the cause of such differ-
ences could be at the level of AVP translation or AVP release.
To this end, we first quantified SCN-AVP content in vivo at
four time points. In addition, differences in SCN-AVP
content between the two mouse lines were investigated at
early postnatal times in vivo as well as in vitro in organotypic
SCN cultures. Second, colchicine, a neuronal transport
inhibitor, was used to establish the total number of SCN-
AVP neurons by detection of cells, which produce AVP even
in minimal quantities. Third, we determined AVP mRNA
expression levels in the SCN at two points in time. Forth, to
characterize not only translation but also release, we
measured AVP release in organotypic SCN cultures of the
two mouse lines. Taken together, this study combines in vivo
and in vitro techniques in order to elucidate the circadian
AVP output system, from mRNAvia production to release of
the protein.2. Material and methods
2.1. Animals
Lines of Mus musculus, bidirectionally selected for
thermoregulatory nest-building behavior for 56 generations
(building small nests (S-mice) or big nests (B-mice)) [4–
6,34], and subsequently randomly bred for 37 generations,
were used. Only males of these mouse lines we employed
for their differences in the number of AVP containing
neurons and circadian organization of locomotor behavior
[1,7–9]. S-mice (more robust circadian organization of
behavior and 1.5-fold more SCN-AVP immunoreactivity
(ir)) and B-mice pups were kept with the mother in large
cages and as adults were housed individually. Food pellets
and tap water were available ad libitum. Cages were placedin a climate-controlled room (20 T 0.5 -C) in a 12:12 light/
dark cycle (lights on at 08:00, 250–350 lux, depending on
cage placement). Principles of laboratory animal care (NIH
publication No. 86-23, revised 1985) were followed and
experiments were approved by the Animal Experimentation
Committee of the University of Groningen (DEC No. 2091
and 1093) and University of Alaska Fairbanks Institutional
Animal Care and Use Committee (protocol #00-06).
2.2. Experimental protocols
2.2.1. Experiment 1: in vivo and in vitro SCN-AVP content
in adult and immature S-mice and B-mice
Three months old adult male mice (n = 40) kept under a
12:12 light/dark cycle were used. Ten mice (5 S- and 5 B-
mice) were sacrificed at each of the four time points ExT 0,
6, 12, and 18 (External time (ExT) 0 = middle of darkness
[11], corresponding to zeitgeber time (ZT) 18, 0, 6, and 12
(ZT 0 is defined as time of lights on)), respectively, and
SCN-AVP content was determined by immunocytochemis-
try. Mouse SCN-AVP peptide content peaks around ExT 10
and reaches a trough between ExT 18 and ExT 2 in rodents
[23–25,41,50]. Therefore, the 4 chosen time points will
describe the circadian variation of SCN-AVP peptide
content adequately.
SCN-AVP immunoreactivity of pups at PD10 (postnatal
day 10 (PD10), day of birth was PD0, n = 7 for each line)
and juveniles (PD24, n = 8 for each line) was compared
between S-mice and B-mice. In vitro SCN-AVP immunor-
eactivity after 14 days of organotypic culturing was also
compared between the lines. These time points were chosen
because PD10 was the age at which pups were sacrificed for
organotypic SCN culturing in experiment 4, while PD24
represents a similar age to the time point at which SCN-AVP
release was evaluated in organotypic culturing. All animals
were sacrificed between ExT 8 and 10.
2.2.2. AVP immunocytochemistry
Animals were deeply anesthetized with an overdose of
sodium pentobarbital (100 mg/kg, intraperitoneal.) and
killed by decapitation, followed by a quick dissection of
the brain. Thereafter, brains were immersion fixed for 24 h
in 4% paraformaldehyde in 0.1 M phosphate buffer (PFA,
pH 7.4) at 4 -C. Subsequently, brains were stored in 0.01 M
phosphate buffered saline (PBS, pH 7.4) with 0.1% NaN3.
Before sectioning on a cryostat, brains were cryoprotected
in 30% phosphate buffered sucrose for 24 h. Coronal brain
sections were cut at a thickness of 25 Am, and collected in
three sets of evenly spaced sections and stored in PBS with
0.1% NaN3 at 4 -C until further processing. Brain sections
were rinsed in PBS and quenched with 0.1% H2O2 for 20
min, followed by three rinses with PBS. Thereafter, brain
sections were preincubated with 5% normal sheep serum
and subsequently incubated overnight with the primary
monoclonal antibody mouse anti-AVP (PS41; 1:500; a gift
of Dr. Gainer, Bethesda, M.D.; [2]) at room temperature.
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(5%), and incubated with biotinylated sheep anti-mouse
(1:200; Amersham, England) for 2 h at room temperature.
After thoroughly rinsing with PBS, the sections were
exposed to HRP-conjugated Streptavidin (1:200; Zymed,
CA) for 2 h at room temperature. Triton X-100 (0.5%) was
added during all incubation steps. Finally, the sections were
processed with diaminobenzidine (DAB)-H2O2 (30 mg
DAB in 100 ml PBS + 0.01% H2O2) under visual guidance.
For the organotypic SCN cultures, all immunocytochem-
ical incubation and rinsing steps were done while the culture
remained attached to the coverslip in the culture tube. The
cultures were immersion fixed in 4% PFA for 2 h at room
temperature. Thereafter, cultures were rinsed in PBS, and
immunocytochemical staining for AVP was performed.
2.2.3. Quantitative analyses of AVP immunoreactivity
AVP-ir in the SCN was quantified by counting the
number of AVP-ir cells [7,17,44,46] and/or by optical
densitometry of AVP-ir with a Quantimet 600 image analysis
system [46]. Both quantitative analyses were performed
‘‘blind’’ to mouse line, condition, and circadian time point.
In short, AVP-positive SCN cells were counted (left and
right hemisphere were summed) in every second section in
pups and juveniles, and every third section in adult mice.
AVP staining clearly defines the borders of the SCN. The
counts in the sections were assigned to seven levels, equally
distributed along the rostro-caudal axis within the SCN.
Counts of the two sections containing the middle portion of
the SCN (mid SCN; rostro-caudal levels 3 and 4) were
summed and taken as a measure of SCN-AVP immunor-
eactivity. Cell counts of AVP-ir cells in organotypic cultures
were performed in the area of the neuronal zone containing
the SCN (left and right hemispheres were summed). The
Optical density (ODs) of AVP-ir in the SCN was measured
in the same sections containing the SCN. OD of AVP-ir of
brain sections was also determined in the paraventricular
nucleus of the hypothalamus (PVN). Two sections contain-
ing the mid-PVN were chosen and counts of left and right
hemispheres were summed.
The OD is expressed in arbitrary units corresponding to
grey levels using a Quantimet 600 image analysis system
[46]. The value of background labeling was measured in an
area devoid of AVP cell bodies, fibers, or punctae (a
hypothalamic region for the brain sections, and a region in
the neuronal zone for the organotypic cultures). The OD of
the area of interest was related to the background value by
the formula [Optical Density  Optical Densitybackground] /
Optical Densitybackground], thus eliminating the variability in
background staining among sections.
2.2.4. Experiment 2: in vivo colchicine injections in S-mice
and B-mice
Colchicine was injected into the lateral ventricle to
abolish axonal transport of AVP and SCN-AVP content was
determined by immunocytochemistry.2.2.5. Colchicine injections and AVP immunocytochemistry
Accumulation of AVP in the cell body was induced by
injection of colchicine, which depolymerizes microtubules
preventing AVP transport from the cell body to the terminals
[33]. Mice were anesthetized by intraperitoneal injection of
ketamine (ketaset 76 mg/kg) and medetomidine (Domitor 1
mg/kg). Using standard sterile surgical procedures, colchi-
cine injections (20 Ag total) into the lateral ventricle were
performed using the following stereotaxic coordinates: 1.0
mm anterior to bregma, 0.7 mm lateral to the midline, and
2.8 mm below the top of the skull. After completion of the
surgical procedure, the anesthetic was reversed by subcuta-
neous injection of atipamezole hydrochloride (Antiseden, 1
mg/kg). The animals were placed on a heated water blanket
throughout the surgery and until fully ambulatory. After
recovery from anesthesia, the mice were immediately
returned to the original housing conditions. Non-injected
control mice were housed individually and disturbance was
kept at a minimum before perfusion after 24 or 48 h
following the injection. The 24- and 48-h time points did not
differ for both lines (S-mice: 1742 T 101 and 1621 T 92; B-
mice: 1746 T 35 and 1675 T 55, respectively) and were
pooled for analysis. Anesthesia for perfusion was given
between ExT 14 and 15 with minimal disturbance and noise.
For perfusion, mice were deeply anesthetized by intra-
peritoneal injection of sodium pentobarbital (100 mg/kg)
and perfused intracardially with 0.9% saline followed by 4%
PFA in 0.1 M PBS buffer, pH 7.3. Mice were perfused in
pairs of one S-mouse and one B-mouse. After perfusion,
brains were removed and postfixed for 1–2 h and
subsequently cryoprotected in 30% phosphate buffered
sucrose at 4 -C. Coronal sections of 20 Am were cut on a
cryostat microtome. AVP immunocytochemistry was per-
formed as described in experiment 1 with the exception that
the secondary antibody was replaced by a biotinylated goat
anti-mouse IgG (Vector 1:200) and subsequently exposed to
avidin/biotinylated horseradish peroxidase macromolecular
complex (Vector, Vectastain ABC kit) and triton X-100
(0.1%) for 30 min at room temperature. DAB processing
was done as described in experiment 1. SCN-AVP neuronal
counts were performed as described in experiment 1.
2.2.6. Experiment 3: in vivo SCN-AVP mRNA expression in
the S-mice and B-mice
Transcription levels of AVP mRNA in the SCN were
measured at mid dark (ExT 0) and mid light period (ExT
12), at which time SCN-AVP mRNA expression reaches
near peak and near trough expression levels [10,12].
2.2.7. AVP-mRNA hybridization
AVP mRNA hybridization was kindly carried out by Dr.
L. Yan and Dr. R. Silver; Columbia University, NY USA.
The AVP cDNA fragment-containing vectors (gift of Dr. H.
Okamura; Kobe University, Japan) were linearized with
restriction enzymes (PstI, Promega) and used as templates
for sense or anti-sense cRNA probes. Digoxigenin-labeled
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Mannheim, Mannheim, Germany) with a standard protocol
for cRNA synthesis [52]. Sense AVP probe revealed no
specific hybridization signals in brain sections (data not
shown).
Serial coronal sections (40 Am) were made from the
rostral to the caudal end of the SCN using a cryostat
(Reichert-Jung, Heidelberg, Germany), alternate sections
were processed in situ. To minimize variations in the
hybridization procedure, sections from the two mouse lines
were processed simultaneously in the same well, by
uniquely marking individual brains with different cortical
knife cuts. The in situ hybridization histochemistry was
performed as described previously [51].
For quantification of optical density, images of serial
sections were captured using a CCD video camera (Sony
XC77) attached to a light microscope (BH-2; Olympus
Optical, Tokyo, Japan). Expression of mRNA was quanti-
fied using the NIH Image program (version 1.61). The grey
value per pixel was averaged and used to quantify the
intensity of the signal in the SCN. For each animal, each
bilateral SCN was evaluated in 3 sections taken from the
mid-SCN region and the average for each animal was used
for statistical evaluation. The SCN was delineated based on
the outline of AVP mRNA staining and optic chiasm. A
hypothalamic area adjacent to the SCN, four times as big as
the SCN, was used to measure background. Relative optical
density was calculated as [Optical Density  Optical
Densitybackground] / Optical Densitybackground] [9].
2.2.8. Experiment 4: SCN-AVP release in organotypic
cultures of S-mice and B-mice
Organotypic SCN cultures were made from 10-day-old
pups. After 12 days, medium samples were taken every 2 h
for AVP release measurements during a 50-h period.
2.2.9. Preparation of organotypic SCN cultures
SCN explants were performed according to the organo-
typic slice culture technique using the roller-drum method
under sterile conditions [15,45]. In short, male pups were
decapitated at PD10. The brains were quickly removed and
a block of hypothalamic tissue containing the bilateral SCN
was cut coronally in 400 Am thick slices using a tissue
chopper. Slices containing the SCN were trimmed. The
absence of PVN and SON tissue was confirmed by AVP
immunocytochemistry (data not shown). The trimmed slices
were placed in Gey’s balanced salt solution, and cooled for
2 h at 4 -C. Slices were embedded in a plasma clot (10 Al
chicken plasma and 10 Al thrombin) on a coverslip and
placed in a culture tube with 700 Al of culture medium (25%
horse serum, 45% Eagle’s basal medium with 62 mM d-
glucose and 4.16 mM NaHCO3, and 30% Hanks balanced
salt solution with 4.16 mM NaHCO3). The SCN slice was
then cultured at 36 -C and rotated at 12 revolutions/h. The
medium was replaced once or twice a week. The culture
stability after 11 days [15,45] indicates that most cell deathhas occurred prior to the sampling period. Drawings as well
as photomicrographs were made by phase-contrast micro-
scopy. After 11 days of culturing, culture medium was
replaced by sample medium (10% horse serum, 60% Eagle’s
basal medium, and 30% Hanks’ balanced salt solution).
Twenty-four hours later, samples were collected from each
culture by changing the sample medium (700 Al) every 2 h
for 2 days (25 time points). The collected medium was
immediately frozen in liquid nitrogen and stored at 20 -C
until analysis. Three out of nine cultures from each line did
not remain intact, i.e., pieces of tissue had detached from the
coverslip, after the sampling period (50 h). At the end of the
experiment (14 days after brain slice preparation), SCN
cultures were immediately fixed in 4% PFAwhile remaining
attached to the coverslip and subjected to AVP immunocy-
tochemistry. AVP immunocytochemistry was performed
while the cultures remained attached to the coverslip (as
described earlier). AVP release per neuron was calculated by
dividing the total release by the total number of AVP
immunoreactive cells.
2.2.10. Radioimmunoassay for AVP
Radioimmunoassay (RIA) for AVP was performed as
described before [27,46]. 240 Al of each sample was
analyzed using a highly sensitive RIA for AVP according
to Watanabe et al. [48], with minor modifications. In short,
we used rabbit anti-AVP (‘‘Peter’’; The Netherlands Institute
for Brain Research, Amsterdam) in a final dilution of
1:16,000. For each tube, 50 Al of SAC-CEL solid phase
secondary antibody coated cellulose suspension (IDS,
England) was used as precipitation reagent. Standard curves
ranged from 0.25 to 64 pg AVP per 50 Al and the assay had
a detection limit of 0.25 pg/ml. Cross-reactivity of ‘‘Peter’’
besides AVP was 0.04% with vasotocin, and <0.01% with
oxytocin. 240 Al of all samples was analyzed in triplicate
(80 Al per tube). The interspecific assay coefficient of
variation was 12%. Individual RIA values within a triplicate
were discarded when the value deviated more than 7% from
triplicate mean. This arbitrary criterion was chosen based on
the variation found in all triplicate RIA values.
2.2.11. Analysis of in vitro AVP release
An acknowledged mathematical algorithm for detecting
peaks in hormonal release is the CLUSTER pulse detection
algorithm [47]. CLUSTER analysis detects peaks by
performing pooled t tests on a bipartite sliding bin (cluster).
We modified the algorithm by introducing a minimum inter-
bin gap of 2 sample points, in order to take into account the
width of nadirs and peaks. This resulted in a 3  3
comparison of nadir and peak samples (a = 0.05, df = 4),
with 2 sample points in between. A peak was defined as the
period between a significant increase and the first following
significant decrease. Number of peaks and duration of peaks
were identified for both lines.
The amplitude of AVP release was measured by taking the
difference between maximal and minimal release. Autocor-
D.R. Van der Veen et al. / Brain Research 1060 (2005) 16–2520relation analysis was performed on individual culture data
with post hoc Friedman repeated-measure ANOVA to
determine the presence of significant period values.3. Results
3.1. Experiment 1: in vivo and in vitro SCN-AVP content in
adult and immature S-mice and B-mice
Numbers of AVP-ir positive cells in vivo were compared
at four time points (ExT 6, 12, 18, and 0; corresponding to
respectively zeitgeber time 0, 6, 12, and 18 [11]) using adult
mice. No circadian differences were found in the S-mice
(Fig. 1). In contrast, B-mice showed circadian variation
(ANOVA time effect; P < 0.001), with higher numbers of
AVP-ir cells at the onset of the light period (ExT 6; Tukey;
P < 0.05; Fig. 1). The differences observed between the lines
in number of AVP-ir cells were an effect seen in the whole
SCN and could not be attributed to a possible subdivision
(ventro-lateral or dorso-medial) of the SCN. Region speci-
ficity and quality of the staining technique were confirmed
by inspection of the PVN of the hypothalamus, which
revealed abundant AVP immunoreactivity. The PVN did not
reveal fluctuations in AVP content in the light period (mean
ODs at ExT 6, 12, and 18: for S-mice: 2.09, 2.67, 2.42, and
for B-mice: 2.22, 2.40, and 1.91, respectively) showing that
fluctuations in the SCN-AVP-ir were region-specific.
The SCN-AVP system of mice at PD10 and PD24 was
compared between the S-mice and the B-mice. In bothFig. 1. Quantification of the number of AVP-positive cells in the SCN of S-
mice (black squares) and B-mice (grey circles) at ExT 0, 6, 12, and 18
(n = 5 per ExT and mouse line). Asterisk indicates a significant difference at
ExT 6 for B-mice (Tukey; P < 0.05). Two-way ANOVA revealed an overall
difference between the B-mice and S-mice where the S-mice showed
significant ( P < 0.05) higher numbers of AVP-ir positive neurons.mouse lines, at PD10, AVP-ir somata were distributed
similarly as seen at PD24 and in adulthood. A large cluster
of AVP-positive cells was present along the dorsomedial
SCN (‘‘SCN-shell’’, [35]), and a smaller cluster at the
ventrolateral SCN (‘‘SCN-core’’, data not shown). At PD10,
however, AVP-ir in cell bodies and fibers was low in both
lines, and no densely stained cells were yet present in
contrast to PD24. Quantitative analyses revealed no differ-
ences in AVP expression between the lines at PD10, neither
in OD of AVP-ir neurons (Fig. 2A) nor in number of AVP-
positive neurons (mean values T SEM for OD at PD10 for S-
mice = 368 T 55, for B-mice = 300 T 27, MWU-test; P >
0.05). Significant differences between the lines were present
at PD24, where S-mice had 47% higher AVP OD values (t
test; P < 0.05; Fig. 2) and a 49% larger number of SCN-AVP
neurons (S-mice 661 T 17; B-mice 445 T 7; MWU-test; P <
0.001). AVP content in the mid SCN was significantly
higher at PD24 compared to PD10 within both lines (MWU-
test; P < 0.01 for both lines).
Comparison of AVP-ir in organotypic cultures between
the two mouse lines was performed 14 days after the start of
the culture, which is comparable to PD24, on cultures that
remained intact after 50-h of sampling for AVP release (6
out of 9 for each line). Two types of AVP-ir neurons were
discerned; densely and lightly stained cells (Table 1). No
difference in the number of lightly stained cells was found
between the lines (MWU-test; P = 0.2298). S-mice cultures
contained significantly higher numbers of densely stained
cells in the neuronal zone than B-mice cultures (MWU-test;
P < 0.01). As a consequence, the total number of AVP cells
also differed between the lines (MWU-test; P < 0.01). The
OD values of AVP-ir were significantly higher (approx-
imately 2-fold) in S-mouse cultures compared to B-mouse
cultures (MWU-test; P < 0.05; Table 1).
3.2. Experiment 2: in vivo colchicine injections in S-mice
and B-mice
AVP-ir cell counts of each of the 7 sections through the
SCN showed significant differences (ANOVA; P < 0.001),
where in non-injected control mice the S-mice had
consistently higher numbers of AVP-ir neurons than the
B-mice (Tukey t test; P < 0.001), while the counts from the
colchicine-injected mice were similar for both lines (Fig. 3).
After colchicine injection, a significantly higher accumu-
lation of AVP in the SCN of B-mice occurred (Tukey t test;
P < 0.001) raising it to the same level as S-mice, while in S-
mice, no significant rise in cellular AVP was seen.
3.3. Experiment 3: in vivo SCN-AVP mRNA expression in
the S-mice and B-mice
SCN-AVP mRNA levels were evaluated by in situ
hybridization at midsubjective day (ExT 12) and midsub-
jective night (ExT 24) (Fig. 4). In situ hybridization revealed
that AVP mRNA levels in the SCN did not differ between the
Fig. 2. Quantification (A) of AVP-ir in the mid-SCN region of pups at PD10 (n = 7 per mouse line) and juveniles at PD24 (n = 8 per mouse line) of B-mice
(grey bars) and S-mice (black bars). Panels B and C show photomicrographs depicting AVP-ir in the SCN in juvenile (PD24) S-mice (B) and B-mice (C).
Asterisk depicts a significant difference between the two lines at PD24 (P < 0.05). OC = optic chiasm; scale bar = 100 Am.
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cantly lower at ExT 24 than at ExT 12 (two-way ANOVA;
P < 0.0001). These data are consistent with published work
that shows a peak of SCN-AVP mRNA expression around
ExT 14 and a trough around ExT 2 [10,12].
3.4. Experiment 4: SCN-AVP release in organotypic
cultures of S-mice and B-mice
SCN tissue from S-mice and B-mice was explanted at
PD10. 12 days after explanting, AVP release from SCN
cultures was measured every 2 h over a period of 50 h.Table 1
Changes of the SCN-AVP system in organotypic SCN cultures
S-mice B-mice
AVP release
Averaged number of peaks in 50 h 2.0 T 0. 9 1.5 T 0.5
Averaged duration of AVP peak (h) 4.2 (T1.7) 3.9 (T2.3)
Averaged amplitude of largest AVP
peak (pg)
65.70 T 15.72 125.70 T 53.91
# cultures with period according to
auto correlation
2 5
Averaged period (h) 23.0 T 1.41 26.4 T 1.30
AVP-ir
Number of SCN-AVP-positive cells:
Densely stained cells 144.2 T 20.7** 38.2 T 12.4
Weakly stained cells 100.5 T 13.6 79.0 T 11.1
Total stained cells 244.7 T 16.7** 117.2 T 15.1
AVP content in neuronal zone
containing the SCN (OD)
0.48 T 0.10* 0.20 T 0.04
Surface area of neuronal zone
(*105 Am)
1.16 T 0.19 1.16 T 0.11
* P < 0.05.
** P < 0.01.Representative AVP release profiles (expressed as percent-
age of the mean) of both S-mouse and B-mouse cultures are
presented in Fig. 5. CLUSTER analysis revealed at least
one, and never more than 3 peaks in AVP release per
culture. B-mouse cultures showed an average of 1.5 peaks
per culture during the 50 h sample period, with an average
duration of 3.9 (T2.3) h. S-mouse cultures showed 2 peaks
on average, with a duration of 4.2 (T1.7) h. Neither number
of peaks (MWU-test; P > 0.05) nor duration of peaks
(MWU-test; P > 0.05) were significantly different between
the lines (Table 1). The average amplitude of the largest
AVP peak per culture was approximately 2-fold higher in B-
mouse cultures compared to S-mouse cultures, but did notFig. 3. Quantification of AVP-positive cells in the SCN of control and
colchicine injected B-mice (grey bars) and S-mice (black bars) (n = 9–
12 per mouse line, per condition). Asterisk depicts a significant
difference between control B-mice and other groups (ANOVA; P <
0.001; Tukey; P < 0.001).
Fig. 6. SCN-AVP release per neuron (expressed in pg/2 h) for individual
B-mice and S-mice cultures (black circles) and box plot with median, 25
and 75% interval. Averaged values for B-mice and S-mice cultures (black
horizontal lines) reveal a significant higher amount of AVP release per
AVP neuron in B-mice, indicated by the asterisk (*P < 0.01; MWU).
Fig. 4. Relative optical density measures of AVP mRNA in the SCN of B-
mice (grey bars) and S-mice (black bars) at ExT 12 and ExT 24. Asterisk
depicts a significant (P < 0.0001) difference between ExT 12 and ExT 24 in
both lines.
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and S-mouse cultures, respectively; MWU-test; P > 0.1;
Table 1). Autocorrelation analysis revealed that, in those
cases where a circadian period could be calculated, the
average period in S-mouse cultures was shorter than that in
B-mouse cultures (Table 1).
Total AVP release over 50 h was determined by
summation of all 2-h samples. B-mouse cultures showed a
34% higher release than S-mouse cultures, but this was not
significantly different (310.2 T 43.43 versus 230.8 T 45.1 pg
in 50 h for B-mouse and S-mouse cultures, respectively;
MWU-test; P > 0.05).
SCN-AVP immunoreactivity performed on the cultures,
after the 50 h sampling for release, indicated that the S-miceFig. 5. Examples of AVP release (expressed as the percentage of the mean of AV
and S-mice. Different culture numbers indicate cultures from different mice. Aldisplayed a significantly higher number of total AVP-ir cells
(experiment 1). To take into account this mouse line
difference and the variation among cultures, we expressed
AVP release per number of AVP-ir neurons (per 2 h) (Fig.
6). B-mouse cultures showed significantly higher (>3-fold)
AVP release per neuron than S-mouse cultures (MWU-test;
P < 0.01; Fig 6).4. Discussion
Previously, we found a 1.5-fold larger number of SCN-
AVP neurons in adult S-mice compared to B-mice [7].P release over 50 h), from organotypic SCN cultures made from B-mice
so see Table 1.
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study including different external times. Differences in the
number of SCN AVP-ir neurons between the two mouse
lines are not due to different numbers of SCN-AVP
producing neurons, because the mouse lines did not differ
in the number of SCN-AVP-ir neurons after colchicine
treatment. Furthermore, AVP mRNA expression levels were
similar between the mouse lines supporting the idea that the
difference in the number of SCN AVP-ir neurons is not due
to different transcription levels. Organotypic SCN cultures
of B-mice showed more AVP release per neuron than
cultures of S-mice. Taken together, our results suggest that
on a mechanistic level S-mice and B-mice differ in transport
and/or release of AVP in the SCN, rather than in regulation
of AVP gene transcription or the number or AVP producing
cells.
Low amino transmitter content due to a higher level of
release has been suggested for a variety of SCN neuro-
peptides [40,17]. As a possible consequence of release, AVP
levels dropped below immunocytochemical detection levels,
and therefore the counts of AVP-ir neurons decreased. This
interpretation is further supported by the differences in AVP
release per AVP neuron in SCN explant cultures of the two
lines. However, when SCN-AVP cells drop below immu-
nocytochemical detection levels, caused by high release, it
could be that in both S- and B-cultures the same overall
numbers of SCN-AVP cells are present, as seen after
colchicine injections in vivo. In the case of identical
numbers of AVP cells in the cultures of either lines, the
release per AVP immunoreactive neuron is an overestima-
tion for the cultures made of B-mice, as a result of lower
AVP peptide levels. This differential SCN-AVP release or
transport also, at least in part, seems to be reflected in the
higher amplitude of release in cultures of B-mice (Table 1).
The difference in SCN-AVP content between the S-mice
and the B-mice was present as early as PD24, but not at
PD10. Although the SCN-AVP system was not fully
expressed at PD10, AVP expression in the mouse SCN
has been reported as early as embryonic day 16 [21]. SCN-
AVP expression increased from PD10 to PD24 in both
mouse lines similarly to what has been observed in rat and
hamster [13,14]. In contrast, mice derived from BALB/cJ 
C57BL/6JN revealed no further maturation of SCN-AVP
expression after PD6, neither in cell number nor in cell size,
although a trend in AVP OD increase was present from PD6
to PD30 [19].
Our AVP mRNA results do not support differences in
transcriptional control of SCN-AVP between the lines. Of
course, we cannot exclude that differences at other time
points than the two key time points we chose could be
present. The higher level of SCN-AVP release per AVP
neuron in the B-mice supports this. Differences in SCN-
AVP release could originate at the level of axonal
transport and/or release of the AVP peptide at the axon
terminal. Indeed, large scale gene expression profiling in
mice revealed circadian variation in a number of genetranscripts coding for proteins involved in presynaptic
vesicle availability [37]. One possible explanation is that
neurons from the S-mice do not receive or do not respond
to stimuli for circadian release. Quantities of AVP
accumulation after colchicine injections do not suggest
that degradation of AVP is a rate-limiting factor in this
model.
High levels of SCN-AVP immunostaining have been
observed in non-rhythmic voles compared to rhythmic ones
[17,26], and in wild-type hamsters compared to tau-mutant
hamsters [46], whereas AVP release was significantly higher
in rhythmic voles [27] and tau-mutant hamsters [46]. When
high levels of SCN-AVP immunoreactivity indicate low
levels of AVP release [17,40], high AVP immunoreactivity
reflects a less dynamic SCN-AVP system. Our results
support this statement, because we found high levels of
AVP immunoreactivity and low levels of AVP release in the
SCN of S-mice compared to B-mice.
AVP release in SCN cultures of S- and B-mice do not
show differences in number of peaks during the 50 h
sampling period. The intrinsic periods of S- and B-mice
differ only by 13 min under free-running conditions [8] and
this difference has been inconsistent (unpublished data). The
amplitude of peak SCN-AVP release is less in S-mice,
indicating a less robust circadian rhythm of release. Release
per neuron is also less in S-mice compared to B-mice.
Although our results thus indicate that AVP release in the
S-mice is less circadian and less abundant, circadian
organization of behavior is more pronounced [8,9]. We
initially expected that the S-mice would have a more robust
circadian system with higher AVP release amplitude and
precision in periodicity compared to B-mice, based on
previous analyses of circadian rhythmicity in locomotor
activity [8,9]. Although the circadian rhythmicity seems to
be more pronounced in S-mice, amplitudes of phase
responses to a light pulse are less than for B-mice [8].
Possibly, this positive correlation between phase responses
and SCN-AVP release is indicative of a different level of
control, where higher levels of AVP output increase the
susceptibility of the circadian system to shifts. Also in mice
selected for high levels of voluntary wheel running, no
correlation between SCN-AVP content and circadian organ-
ization of wheel-running activity was seen [20], suggesting
that in these mice SCN-AVP may not be directly involved in
circadian locomotor behavior. The Brattleboro rat, effec-
tively lacking AVP due to a point mutation in the AVP gene,
does show circadian organization of behavior, but with a
lower amplitude [38]. However, in the common vole SCN-
AVP release is positively correlated with robustness of
circadian organization of locomotor behavior [17,26–28].
Species-specific correlations are also reflected in protein
kinase C signal transduction, which show differential
expression, both in levels and circadian variation [[9] and
references therein]. In conclusion, although differences in
SCN-AVP are strongly correlated with differences in
behavior, these correlations are in a different direction
D.R. Van der Veen et al. / Brain Research 1060 (2005) 16–2524depending on the species, and thus do not reflect a general
characteristic of SCN-AVP content.Acknowledgments
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